JP2002527481A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002527481A5 JP2002527481A5 JP2000576854A JP2000576854A JP2002527481A5 JP 2002527481 A5 JP2002527481 A5 JP 2002527481A5 JP 2000576854 A JP2000576854 A JP 2000576854A JP 2000576854 A JP2000576854 A JP 2000576854A JP 2002527481 A5 JP2002527481 A5 JP 2002527481A5
- Authority
- JP
- Japan
- Prior art keywords
- medicament according
- medicament
- androstene
- dione
- mammal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/174,235 US6153606A (en) | 1998-10-16 | 1998-10-16 | Memory enhancement by the administration of Δ5-androstene-3β-ol-7,17-dione and 3β esters thereof |
| US09/174,235 | 1998-10-16 | ||
| PCT/US1999/024076 WO2000023080A1 (en) | 1998-10-16 | 1999-10-13 | IMPROVING MEMORY BY THE ADMINISTRATION OF Δ5-ANDROSTENE-3β-OL-7,17-DIONE AND 3β ESTERS THEREOF |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002527481A JP2002527481A (ja) | 2002-08-27 |
| JP2002527481A5 true JP2002527481A5 (https=) | 2007-01-25 |
Family
ID=22635389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000576854A Pending JP2002527481A (ja) | 1998-10-16 | 1999-10-13 | 哺乳動物の記憶を改善する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6153606A (https=) |
| EP (1) | EP1123100B1 (https=) |
| JP (1) | JP2002527481A (https=) |
| AT (1) | ATE289819T1 (https=) |
| CA (1) | CA2344677A1 (https=) |
| DE (1) | DE69923988T2 (https=) |
| WO (1) | WO2000023080A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6153606A (en) * | 1998-10-16 | 2000-11-28 | Humanetics Corporation | Memory enhancement by the administration of Δ5-androstene-3β-ol-7,17-dione and 3β esters thereof |
| US6667299B1 (en) * | 2000-03-16 | 2003-12-23 | Hollis-Eden Pharmaceuticals, Inc. | Pharmaceutical compositions and treatment methods |
| US7553829B2 (en) * | 2000-11-30 | 2009-06-30 | Humanetics Corporation | Treatment of chronic fatigue syndrome and fibromyalgia syndrome |
| US6399084B1 (en) | 2001-03-05 | 2002-06-04 | Humanetics Corporation | Method for diminishing wrinkles and fine lines of the skin by the topical application of Δ5-androstene-3β-ol-7, 17 dione and metabolizable precursors thereof |
| US6399085B1 (en) | 2001-03-05 | 2002-06-04 | Humanetics Corporation | Method of moisturizing the skin by the topical application of Δ5-androstene-3β-ol-7,17 dione and metabolizable precursors thereof |
| US6465446B1 (en) | 2001-03-12 | 2002-10-15 | John C. Dykstra | Treatment of dermatitis by the topical application of Δ5-androstene-3β-ol-7,17 dione and metabolizable precursors thereof |
| US8084446B2 (en) * | 2005-04-26 | 2011-12-27 | Eric Marchewitz | Use of DHEA derivatives for enhancing physical performance |
| WO2007103548A2 (en) | 2006-03-09 | 2007-09-13 | Inflazyme Pharmaceuticals Ltd. | Novel antibiotic compositions |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4791099A (en) * | 1984-10-29 | 1988-12-13 | Chaovanee Aroonsakul | Method of treatment for central nervous system diseases such as Alzheimer's's disease |
| US4812447A (en) * | 1985-10-22 | 1989-03-14 | City Of Hope | Method for the treatment of nervous system degeneration |
| US5292730A (en) * | 1990-08-29 | 1994-03-08 | Humanetics Corporation | Modulation of immune system with Δ5-androstenes |
| US5707983A (en) * | 1990-08-29 | 1998-01-13 | Humanetics Corporation | Treatment of alzheimer's disease and modulation of immune system with Δ5-androstenes |
| US5641766A (en) * | 1990-08-29 | 1997-06-24 | Humanetics Corporation | UP-regulation of immune system with Δ 5-Androstenes |
| US5807848A (en) * | 1990-08-29 | 1998-09-15 | Humanetics Corporation | Use of dehydroepeiandrosterone-3-carboxylates to control body weight |
| US5585371A (en) * | 1990-08-29 | 1996-12-17 | Humanetics Corporation | Treatment of immune system with Δ5-androstenes |
| US5506223A (en) * | 1990-08-29 | 1996-04-09 | Humanetics Corporation | Δ5-androstenes useful for promoting weight maintenance or weight loss and treatment process |
| AU647528B2 (en) * | 1990-08-29 | 1994-03-24 | Humanetics Corporation | Treatment process for promoting weight loss employing a substituted delta5-androstene |
| ATE202707T1 (de) * | 1993-09-02 | 2001-07-15 | Humanetics Corp | Delta - 5 - androstene, die das halten des gewichts oder den gewichtsverlust fördern und behandlungsverfahren |
| US5420028A (en) * | 1993-10-13 | 1995-05-30 | Northeastern Ohio Universities | Truncated human cholesterol 7α-hydroxylase, method of production and use thereof |
| GB9421093D0 (en) * | 1994-10-19 | 1994-12-07 | Univ Edinburgh | Hippocampus-associated proteins, DNA sequences coding therefore and uses thereof |
| US5556847A (en) * | 1994-10-27 | 1996-09-17 | Duquesne University Of The Holy Ghost | Methods of effecting memory enhancement mediated by steroid sulfatase inhibitors |
| EP0954317B1 (en) * | 1996-04-09 | 2007-06-06 | The University Of Edinburgh | Use of 7 apha-substituted steroids to treat neuropsychiatric disorders |
| US6153606A (en) * | 1998-10-16 | 2000-11-28 | Humanetics Corporation | Memory enhancement by the administration of Δ5-androstene-3β-ol-7,17-dione and 3β esters thereof |
-
1998
- 1998-10-16 US US09/174,235 patent/US6153606A/en not_active Expired - Lifetime
-
1999
- 1999-10-13 DE DE69923988T patent/DE69923988T2/de not_active Expired - Fee Related
- 1999-10-13 JP JP2000576854A patent/JP2002527481A/ja active Pending
- 1999-10-13 AT AT99954931T patent/ATE289819T1/de not_active IP Right Cessation
- 1999-10-13 CA CA002344677A patent/CA2344677A1/en not_active Abandoned
- 1999-10-13 WO PCT/US1999/024076 patent/WO2000023080A1/en not_active Ceased
- 1999-10-13 EP EP99954931A patent/EP1123100B1/en not_active Expired - Lifetime
-
2000
- 2000-11-01 US US09/704,495 patent/US6489313B1/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6634400A (en) | Dose of an angiogenic factor and method of administering to improve myocardial blood flow | |
| MXPA01013042A (es) | Acidos aldonicos de oligosacarido y su uso topico. | |
| EE05129B1 (et) | Konjugeeritud strogeenide ja medroksprogesteroonatsetaadi kasutamine, farmatseutiline kompositsioon, doseerimishik ja pakend | |
| PT1410791E (pt) | Forma galénica apta a ser administrada oralmente compreendendo metformina e um agente promotor da absorção | |
| Hall | Prevention and treatment considerations in patients with drug-induced gingival enlargement | |
| AU2003207016A1 (en) | Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor for the treatment of inflammatory and allergic conditions | |
| MD1920F2 (ro) | Compoziţie şi metodă de profilaxie sau frânare a debutului bolii Alzheimer | |
| NO922004D0 (no) | Oralt preparat for behandling av inflammatoriske tarmsykdommer | |
| JP2002527481A5 (https=) | ||
| WO2001030802A3 (en) | Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies | |
| ATE241363T1 (de) | Ungesättigte fettsäure und steroide enthaltende kombinationspräparate zur behandlung von entzündungen | |
| CA2271162A1 (en) | Stearidonic acid compositions and uses thereof | |
| NZ522242A (en) | Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia | |
| NO20023102D0 (no) | Metode og formulering for å behandle motstand mot antihypertensiver og lignende tilstander | |
| IL149360A0 (en) | Method and compositions for administering taxanes orally to human patients | |
| DK1227814T3 (da) | Hormonal sammensætning baseret på nomegestrolacetat og et östrogen samt anvendelse heraf | |
| AR001765A1 (es) | Una formulación de liberación prolongada un procedimiento para su preparación una forma cristalina de cisaprida-(l)-tartrato y un medicamento util para el tratamiento de trastornos gastrointestinales | |
| AU2001257406A1 (en) | Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941 | |
| JP2004261599A5 (https=) | ||
| WO2000018353A3 (en) | A novel inhibitor of cataract formation | |
| WO2001085188A3 (en) | Use of echinacea as a hematinic agent | |
| DE69923988D1 (de) | Gedächnissverbesserung durch verabreichung von delta-5-androsten-3-beta-ol-7,17-dion und 3-beta-estern desselben | |
| JP2003522795A5 (https=) | ||
| JP2003522737A5 (https=) | ||
| WO2003043579A3 (en) | Methods and compositions for the treatment of pain and other hormone-allergy-related symptoms using dilute hormone solutions |